The top NIH official said that remdesivir will become the standard of care for COVID-19 after its early clinical trial results showed it helped COVID-19 patients recover more quickly and reduces death rate …
The top NIH official said that remdesivir will become the standard of care for COVID-19 after its early clinical trial results showed it helped COVID-19 patients recover more quickly and reduces death rate …